Butanoic acid;N-(2-hydroxyethyl)-4-oxo-N-propan-2-yl-3,5-dihydropyrrolo[2,3-c]quinoline-8-sulfonamide
C20H27N3O6S — CID 68934630
Data last refreshed: (MolForge compound catalog, from PubChem)
About Butanoic acid;N-(2-hydroxyethyl)-4-oxo-N-propan-2-yl-3,5-dihydropyrrolo[2,3-c]quinoline-8-sulfonamide
Butanoic acid;N-(2-hydroxyethyl)-4-oxo-N-propan-2-yl-3,5-dihydropyrrolo[2,3-c]quinoline-8-sulfonamide (PubChem CID 68934630) has the molecular formula C20H27N3O6S and a molecular weight of 437.52 g/mol. Its IUPAC name is butanoic acid;N-(2-hydroxyethyl)-4-oxo-N-propan-2-yl-3,5-dihydropyrrolo[2,3-c]quinoline-8-sulfonamide.
Molecular Properties
| Compound Name | Butanoic acid;N-(2-hydroxyethyl)-4-oxo-N-propan-2-yl-3,5-dihydropyrrolo[2,3-c]quinoline-8-sulfonamide |
|---|---|
| PubChem CID | 68934630 |
| Molecular Formula | C20H27N3O6S |
| Molecular Weight | 437.52 g/mol |
| Exact Mass | 437.16 |
| IUPAC Name | butanoic acid;N-(2-hydroxyethyl)-4-oxo-N-propan-2-yl-3,5-dihydropyrrolo[2,3-c]quinoline-8-sulfonamide |
| SMILES | CC(C)N(CCO)S(=O)(=O)c1ccc2[nH]c(=O)c3[nH]ccc3c2c1.CCCC(=O)O |
| InChI | InChI=1S/C16H19N3O4S.C4H8O2/c1-10(2)19(7-8-20)24(22,23)11-3-4-14-13(9-11)12-5-6-17-15(12)16(21)18-14;1-2-3-4(5)6/h3-6,9-10,17,20H,7-8H2,1-2H3,(H,18,21);2-3H2,1H3,(H,5,6) |
| InChIKey | ADCNZVWQJFVVBF-UHFFFAOYSA-N |
| XLogP | 2.27 |
| TPSA | 143.56 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.52 |
| LogP ≤ 5 | 2.27 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 68934630 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.